This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.8% to $6.96 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.6% to 18,350.19 and Dow Jones Industrial Average falling 1.5% to 43,191.24.
Corbus Pharmaceuticals Holdings Inc. closed 88.8% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 0.8% to $4.72, Fortress Biotech Inc. fell 3.2% to $1.52, and Viking Therapeutics Inc. fell 10.98% to $25.70.
Trading volume totaled 241,567, compared to the 50-day average of 272,326.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 03, 2025 16:33 ET (21:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。